Correlation study between small vessel disease and early neurological deterioration in patients with mild/moderate acute ischemic stroke

International Journal of Neuroscience

Volumn 127, Issue 7, 2017, Pages 579-585

  Chen, Zhonglun ^a,b   Li, Wei ^a   Sun, Wen ^a   Xiao, Lulu ^a   Dai, Qiliang ^a   Cao, Yuezhou ^a   Han, Yunfei ^a   Zhu, Wusheng ^a   Xu, Gelin ^a   Liu, Xinfeng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MIANYANG CENTRAL HOSPITAL   (China)

Author keywords

brain atrophy; cerebral microbleeds; early neurological deterioration; enlarged perivascular spaces; small vessel disease; white matter hyperintensities

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CORRELATIONAL STUDY; DETERIORATION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; NEUROLOGICAL DETERIORATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SILENT MYOCARDIAL INFARCTION; AGED; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; PATHOPHYSIOLOGY;

AGED; BRAIN ISCHEMIA; CEREBRAL SMALL VESSEL DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE;

EID: 84981193893     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207454.2016.1214825     Document Type: Article

References (37)

1. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease:insights from neuroimaging. Lancet Neurol 2013;12(5):483–97.
2. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12(8):822–38.
3. Imamine R, Kawamura T, Umemura T, et al. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract 2011;94(1):91–9.
4. Tang WK, Chen YK, Lu JY, et al. Cerebral microbleeds and symptom severity of post-stroke depression:a magnetic resonance imaging study. J Affect Disord 2011;129(1–3):354–8.
5. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging:systematic review and meta-analysis. Brit Med J 2010;341:c3666
6. IST-3 Collaborative Group. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3):secondary analysis of a randomised controlled trial. Lancet Neurol 2015;14(5):485–96.
7. Arba F, Palumbo V, Boulanger JM, et al. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke 2016;11(1):62–7.
8. Curtze S, Haapaniemi E, Melkas S, et al. White matter lesions double the risk of post-thrombolytic intracerebral hemorrhage. Stroke 2015;46(8):2149–55.
9. Huang Z, Yin Q, Sun W, et al. Microbleeds in ischemic stroke are associated with lower serum adiponectin and higher soluble E-selectin levels. J Neurol Sci 2013;15(1–2):83–7.
10. Bechmann I, Galea I, Perry VH. What is the blood–brain barrier (not)? Trends Immunol 2007;29:5–11.
11. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly:molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006;37:1391–8.
12. Koh SH, Park CY, Kim MK, et al. Microbleeds and free active MMP-9 are independent risk factors for neurological deterioration in acute lacunar stroke. Eur J Neurol 2011;18(1):158–64.
13. Del Bene A, Palumbo V, Lamassa M, et al. Progressive lacunar stroke:review of mechanisms, prognostic features, and putative treatments. Int J Stroke 2012;7(4):321–9.
14. Siegler JE, Martin-Schild S. Early neurological deterioration (END) after stroke:the END depends on the definition. Int J Stroke 2011;6(3):211–2.
15. Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke 2009;40:e443–50.
16. Seo WK, Seok HY, Kim JH, et al. C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. J Stroke Cerebrovasc Dis 2012;21:181–6.
17. Lin LC, Lee TH, Chang CH, et al. Predictors of clinical deterioration during hospitalization following acute ischemic stroke. Eur Neurol 2012;67:186–92.
18. Rodriguez-Yanez M, Castellanos M, Blanco M, et al. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology 2006;67:1973–8.
19. Serena J, Rodriguez-Yanez M, Castellanos M. Deterioration in acute ischemic stroke as the target for neuroprotection. Cerebrovasc Dis 2006; 21(suppl 2):80–8.
20. Sun W, Dai J, Xiong Y, et al. Correlation between ABCD, ABCD2 scores and craniocervical artery stenosis in patients with transient ischemic attack. Eur Neurol 2013;70(5–6):333–9.
21. Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds:histopathological correlation of neuroimaging. Cerebrovasc Dis 2011;32(6):528–34.
22. Adams HH, Cavalieri M, Verhaaren BF, et al. Rating method for dilated Virchow–Robin spaces on magnetic resonance imaging. Stroke 2013;44(6):1732–5.
23. Huijts M, Duits A, van Oostenbrugge RJ, et al. Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. A study in first-ever lacunar stroke and hypertensive patients. Front Aging Neurosci 2013;5:72.
24. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987,149:351–6.
25. Farrell C, Chappell F, Armitage PA, et al. Development and initial testing of normal reference MR images for the brain at ages 65–70 and 75–80 years. Eur Radiol 2009;19:177–83.
26. Potter GM, Doubal FN, Jackson CA, et al. Enlarged perivascular spaces and cerebral small vessel disease. Int J Stroke 2015;10:376–81.
27. Liu X, Zhang S, Liu M, et al. Chinese guidelines for endovascular management of ischemic cerebrovascular diseases. Interv Neurol 2012;1:171–84.
28. Lee EJ, Choi KH, Ryu JS, et al. Stroke risk after coronary artery bypass graft surgery and extent of cerebral artery atherosclerosis. J Am Coll Cardiol 2011;57(18):1811–8.
29. Adams Jr HP, Del ZG, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke:a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups:the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655–711.
30. Liu X, Xu G, Wu W, et al. Subtypes and one-year survival of first-ever stroke in Chinese patients:the Nanjing Stroke Registry. Cerebrovasc Dis 2006;22:130–6.
31. Baker JG, Williams AJ, Ionita CC, et al. Cerebral small vessel disease:cognition, mood, daily functioning, and imaging findings from a small pilot sample. Dement Geriatr Cogn Dis Extra 2012;2(1):169–79.
32. Ois A, Martinez-Rodriguez JE, Munteis E, et al. Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 2008;25(1–2):151–6.
33. Suda S, Katsumata T, Okubo S, et al. Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke. Cerebrovasc Dis 2013;36(5–6):388–93.
34. Liu XQ, Sheng R, Qin ZH. The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 2009;30(8):1071–80.
35. Pignataro G, Scorziello A, Di Renzo G, et al. Post-ischemic brain damage:effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy. FEBS J 2009;276(1):46–57.
36. Johnsen D, Murphy SJ. Isoflurane preconditioning protects neurons from male and female mice against oxygen and glucose deprivation and is modulated by estradiol only in neurons from female mice. Neuroscience 2011;199:368–74.
37. Song X, Li G, Vaage J, et al. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 2003;177(4):459–66.